The Joint Blog

AUGUST 15, 2019

Pritzker signed two measure that expands the state’s medical-marijuana program while cementing it into law. The legislation adds chronic pain, autism, anorexia nervosa, irritable bowel syndrome, migraines, polycystic kidney disease, and osteoarthritis as new medical marijuana conditions.

Programs 29

Programs Chronic Pain Marijuana Patients 29

SpeedWeed

MARCH 24, 2021

With the Eastern seaboard’s most ambitious Adult Use program primed to explode, New Jersey’s Superior Court Appellate Division (“Appellate Division”) just lifted its “stay” on scoring 18 month old Medical Marijuana applications clearing the way for 5 cultivation, 15 dispensary, and 4 vertically integrated license awards. 24:6I Et Seq.

Programs 52

Programs Business Cannabis Retail 52

The Cannigma

JULY 1, 2022

Iowa has not legalized adult-use cannabis, but it does have a medical cannabis program. The program is quite limited, with only manufactured products that have a small amount of THC allowed every 90 days. Iowa Medical Marijuana Program. The medical program for Iowa patients is limited. CBD regulations.

Chronic Pain 52

Chronic Pain Legalization Programs Recreational 52

The Cannigma

SEPTEMBER 19, 2021

Along with Corinne Tobias, the co-founder and program director of the Cannabis Coaching Institute, Meharg spoke with The Cannigma about the importance of cannabis coaching in this golden era of legal weed, and how their own journey as patients led them to become cannabis coaches. What a cannabis coach isn’t.

Education 112

Education Patients Cannabis Programs 112

Canna Care Docs

OCTOBER 2, 2020

An applying patient must have a qualifying condition per the Delaware Department of Health and medical records from within the last year confirming the diagnosis. Approved patients will have access to 6 dispensaries throughout the state and may purchase up to 3 ounces every 15 days. As of June 30, 2013.

Patients 52

Patients Conditions Treatment Dispensary 52

Cannabis Law Report

JULY 2, 2022

It was only in 2013 that the country aligned its policy with the rest of the Union and allowed the cultivation of hemp by local farmers. Only a handful of European countries have so far recognized the medical potential of this long stigmatized plant and begun to tentatively set up medical marijuana programs.

Policy 52

Policy History Seed-To-Sale Decriminalization 52

Canna Care Docs

SEPTEMBER 26, 2019

Powered by Sail, we are on a mission to solve the issue of cannabis access for patients. Since 2013, Canna Care Docs has expanded to over 25 locations representing 11 states. Evaluate patient for verification of a qualifying condition. Evaluate patient for verification of a qualifying condition.

History 40

History DEA Therapy Patients 40

Canna Law Blog

NOVEMBER 27, 2021

Notwithstanding its dubious distinction as a Schedule I drug, DMT increasingly is the subject of study for its potential efficacy in treating a wide array of mental-health conditions including depression, anxiety, and PTSD. regulators to launch a clinical program to study the use of DMT for the treatment of stroke-related dysfunction.

Therapy 88

Therapy Clinical Trials DEA Microdosing 88

Veriheal

NOVEMBER 10, 2020

Despite the fact that there are still months before the start of this experiment, Nicolas Authier (chair of the French Agency for Safety of Medicines and Health Products, or ANSM) stated that France is now officially committed to giving citizens access to medical cannabis. . But what is the legal status of cannabis in France ?

Chronic Pain 76

Chronic Pain Pharmaceutical Patients Epilepsy 76

The Cannigma

OCTOBER 20, 2021

In 2012, Switzerland decriminalized the possession of marijuana, and since October 1, 2013, the possession of up to 10 grams of cannabis is subject to an on the spot fine of CHF 100 ($107.8). With a medical cannabis permit, a patient can possess and use these medicines, and access them at participating pharmacies.

Legalization 52

Legalization Decriminalization Patients Medicine 52

Canna Care Docs

SEPTEMBER 23, 2020

Patients may purchase 120 grams of flower or 36 grams of THC extract each month unless their medical provider determines that an increase in this limit is required by the patient due to the severity of the medical condition. This can be as simple as taking a picture of a prescription bottle you have been given to treat your condition.

Patients 52

Patients Conditions Dispensary Cannabis 52

Veriheal

JANUARY 22, 2021

Because until such time as a legislator changes the law the law is clear: you must under existing law provide incarcerated persons with the ability to access medical cannabis free from penalty. Senator Candelaria is an attorney who has served in office since 2013. That’s the law.” The Case That Drove the Change.

Patients 52

Patients Medicine Access Cannabis 52

The Cannigma

FEBRUARY 26, 2021

This is one of the reasons CBG is being researched for such an array of conditions. CBG’s interaction with certain receptors is currently being researched for conditions such as diabetes and obesity, and there are also indicators that suggest it could be researched for ADHD, PTSD and dementia. .

Oil 100

Oil Terpenes Cannabinoids Extraction 100

NORML

DECEMBER 10, 2019

At the time, the state’s legalization bill was one of the most progressive, which included protections for home growers, preservation of one of the nation’s best medical marijuana programs, and a social consumption clause that would’ve made Maine one of the first states to host licensed cannabis bars and lounges.

Legalization 115

Legalization Legislation Education Programs 115

The Cannigma

JUNE 15, 2021

For now, if you have access to quality CBD products, there’s no reason to prioritize CBG products. Charlotte’s story was featured on CNN in 2013 and millions of people saw with their own eyes how a few drops of cannabis oil succeeded where no other epilepsy treatment had —- reducing her seizures from 300 each week to less than three a month.

CBD 122

CBD Research and Development Epilepsy Extraction 122

SpeedWeed

MARCH 6, 2021

Many will be priced out of what patients already complain is a too expensive medical marijuana program, instead seeking out the black market.”. nikkifried says “Our lawmakers should be improving our marijuana program, working on decriminalization, and moving towards legalization for adult use.” ” RT if you agree!

THC 52

THC Patients Law Chronic Pain 52

Cannabis Law Report

MAY 29, 2022

FDA granted Breakthrough Therapy designation for Spravato in 2013 and ultimately approved it for adults who have not responded to treatment after trying other antidepressant medications. Schedule I controlled substances are the most restricted in terms of research, supply, and access, [13] and possession is criminalized. Times (Nov.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JANUARY 20, 2022

Eleusis pioneers the development of psychedelic drug candidates in the life sciences space, with the goal of transforming psychedelics into broadly accessible medicines. Medicines and Healthcare products Regulatory Agency’s Innovative Licensing and Access Pathway (“ILAP”), offering the potential to accelerate time to market.

Therapy 52

Therapy Research and Development Business Access 52

The Cannigma

OCTOBER 25, 2021

In 2018 Canada legalized recreational cannabis use, becoming the first G7 country to do so and only the second country after Uruguay, which legalized cannabis in 2013. Canadian law allows people to receive medical cannabis for any condition or symptoms approved by their personal healthcare practitioner. billion ($5.16 miles) to 6.5

Legalization 106

Legalization Packaging Edibles Retail 106

Cannabis Law Report

JULY 25, 2022

An email sent by the charity stated it had secured the MDMA for the trial and that “this trial will give graduates and participants in our Certificate of Psychedelic- Assisted Therapies (CPAT) Program the chance to actually undergo Psychedelic Assisted therapy in a clinically controlled environment”. MMA says a “breach was innocently made”.

Medicine 52

Medicine Therapy Research and Development Business 52

Cannabis Law Report

MAY 26, 2022

The objective of the current study was to assess the ease of access to marijuana by underage patrons at recreational marijuana outlets in California, where recreational marijuana was legalized in 2016. 2010, Elvik, 2013, Hartman and Huestis, 2013, Rogeberg and Elvik, 2016). 2012, Calabria et al.,

Dispensary 52

Dispensary Research and Development Safety Recreational 52

The Cannigma

SEPTEMBER 28, 2022

The country has a limited medical cannabis program that recognizes Sativex and CBD. Belgium medical cannabis program. The country legalized medical marijuana in 2015, but with a limited scope of diagnosable conditions and products. Cannabis in Belgium. Certain localities such as Antwerp have initiated their own regulations.

Law 73

Law Decriminalization Cultivation Oil 73

Cannabis Law Report

OCTOBER 12, 2021

The brand is being created to represent a focused vision towards becoming a leading house of brands with a mission to empower consumers with access and a variety of trusted cannabis packaged goods. The Company has initiated a rebrand, including seeking a new corporate name and visual identity.

Extraction 52

Extraction Business Hash Events 52

Veriheal

SEPTEMBER 14, 2021

All respondents identified as American military veterans, and the information was pulled from a 2012–2013 National Epidemiologic Survey on Alcohol and Related Conditions–III (NESARC-III). . Senators Voted to Broaden Medical Cannabis Access for Veterans . Sponsored by Sen.

Consumption 97

Consumption Research and Development Treatment Programs 97

Cannabis Law Report

JUNE 11, 2019

Despite the recent legalization of cannabis, a framework for access to cannabis for medical purposes still exists, but under new regulations passed under the authority of the Cannabis Act. Raj , 2013 BCSC 308. Prior to that, cannabis was regulated under the Controlled Drugs and Substances Act. Relevant Principles. 5 Joinson v.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

Cannabis Law Report

SEPTEMBER 23, 2019

Surveying marijuana use is essential to gauge public health implications of increased access to marijuana, cannabinoid, and cannabis products. 2,5,25 Improved sleep was also considered a secondary outcome when evaluating other conditions (chronic pain, multiple sclerosis) with various cannabinoids. and 2.3%, respectively.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

JANUARY 9, 2019

Phoenix, headquartered in Denver, distributes medicinal cannabis products around the globe to treat seven major categories of medical conditions including pain, cancer, autoimmune, metabolic, neurological, psychological and sleep disorders. It also gives us a fast-track program. It’s all about access and education,” said Tindall. “If

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

Healer

JANUARY 17, 2022

People with health conditions for which early research into CBG is showing favorable results, with support and direction from their healthcare providers. As research grows we’ll learn more about the therapeutic potential of CBG in infectious conditions. People who find CBD and/or CBDA too mentally stimulating. CBG vs. CBD.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development THC 52

Healer

JANUARY 17, 2022

People with health conditions for which early research into CBG is showing favorable results, with support and direction from their healthcare providers. As research grows we’ll learn more about the therapeutic potential of CBG in infectious conditions. People who find CBD and/or CBDA too mentally stimulating. CBG vs. CBD.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development THC 52

Cannabis Law Report

JANUARY 29, 2019

Cannabis remains illegal in Switzerland though the law was loosened in 2013, ensuring adults caught with ten grams or less can accept a 100-franc ($100) spot fine, though that is enforced to varying degrees across the country.

Legalization 40

Legalization Medicine Recreational Banking 40

SMPL

MAY 26, 2020

In the absence of oversight, the push to get more patients access to cannabis medicine — and bona fide CBD — has been co-opted by a push to make as much money as possible off the next big wellness fad. “At Alas, Mr. Gardner wrote in 2005, that would require access to expensive testing equipment. They saw the winds were shifting.”.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Medical Cannabis Seedbank

AUGUST 6, 2018

They have noted the Cannabis plant as a great option for a number of conditions. The government implemented a program aimed at granting access to medical cannabis and later modified this to allow cannabis cultivation for medical use. Medical cannabis in this Central European country has been regulated since 2013.

Research and Development 61

Research and Development Cultivation Chronic Pain Cannabis 61

Veriheal

NOVEMBER 7, 2023

The tax money will fund addiction treatment programs, social equity, job programs, municipalities with dispensaries, and other administrative expenses. However, If you have your Ohio medical marijuana card, you can access medical cannabis from a wide range of available dispensaries.

Legalization 120

Legalization Legislation Programs Recreational 120

Sensi Seeds

DECEMBER 10, 2018

Today, there is an enormous quantity and varied quality of scientific data, and this study is a fundamental tool that optimizes the way we access it. While most research took place in the area of psychiatry, publications in the fields of neurology and cancer increased significantly between 2011 and 2013.

Medicine 81

Medicine Research and Development Data Policy 81

Cannabis Law Report

JUNE 4, 2021

David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. Since founding Eleusis in 2013, Shlomi has overseen the company’s corporate and clinical development efforts. in/carhart-harris-robin-19112542/ [link]. David Nutt.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

JANUARY 21, 2019

Track-and-Trace System Reporting Requirements, Section 40513 Track-and-Trace – Loss of Access, Section 40515 Track-and-Trace Temporary Licenses, and Section 40517 Track-and-Trace System – UID Tag Order. All electronic storage systems must provide a complete and accurate record of your data that is accessible to the IRS. .

Seed-To-Sale 40

Seed-To-Sale Business Compliance Compliance 40

SpeedWeed

MAY 7, 2021

After a nearly 10-hour filibuster Tuesday, House lawmakers reconvened Thursday and considered several floor amendments before passing the Senate-originated bill, 68-34, which would allow registered patients diagnosed with qualifying conditions to access cannabis. The legislation, Senate Bill 46 , now heads to Republican Gov.

Legislation 52

Legislation Seed-To-Sale Patients Chronic Pain 52